Mazen Noureddin, MD

Director, Cedars-Sinai Fatty Liver Program

Comprehensive Transplant Center
8900 Beverly Blvd., Suite 270
Los Angeles, CA 90048





Parking Instructions:

Parking is available in the Comprehensive Transplant Center building.

Mazen Noureddin, MD

Director, Cedars-Sinai Fatty Liver Program

  • IM/Gastroenterology
  • Fatty Liver Disease
  • Liver Transplant
  • Hepatology

Fatty Liver Disease [Alcoholic (ALD), Nonalcoholic (NAFLD), Pregnancy]

Hepatitis (A, B, C)

Liver Cancers

Liver Disorders

Liver Failure

Liver Transplants

Upper Gastrointestinal Endoscopy

The research of Mazen Noureddin, MD, focuses on the underlying mechanisms of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), new imaging modalities and exploring new treatments. He has conducted several original studies that have been featured in publications such as Gastroenterology, Hepatology and The American Journal of Gastroenterology, among many others. The Fatty Liver Program at Cedars-Sinai has many breakthrough clinical trials targeting new therapies in patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitisn (NASH), including those with advanced fibrosis and cirrhosis.

  • Residency: University of Southern California, 2005
  • Fellowship: National Institutes of Health, 2008
  • Master's: Duke University School of Medicine, 2009
  • Fellowship: University of California, San Diego School of Medicine, 2011
  • American Liver Foundation (ALF): Health Care Visionary Award, 2016
  • Clinical Scholar Program, Cedars Sinai, 2015
  • Top Doctors, Pasadena Magazine, 2014, 2015
  • AGA-AASLD Academic Skill Workshop. San Diego CA (invited), 2013
  • Young Investigator Travel Award, European Association of Liver Diseases EASL-AASLD HCV Special Conference in Prague, 2012
  • 2nd Award of Research Poster Competition in San Diego Gastroenterology Society, 2012
  • Junior Resident of the Year, University of Southern California, Department of Medicine, 2007
  • Sabina Brautbar Resident Scholar Award of Research, University of Southern California, Department of Medicine, 2007
  • Resident Scholar Travel Award, American Association of Liver Disease, 2007
  • Sabina Brautbar Resident Scholar Award of Research, University of Southern California, Department of Medicine, 2006

Show moreShow less

Click here for a list of peer-reviewed publications.

  • Noureddin M, Khoyliar C, Palmer SL. MRI, CT scan and ultrasound in the diagnosis of nonalcoholic fatty liver disease. J Clin Gastroenterol. 2015;49(4):351-352.
  • Noureddin M, Mato JM, Lu SC. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Exp Biol Med (Maywood). 2015;240(6):809-820.
  • Noureddin M, Rinella ME. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Clin Liver Dis. 2015;19(2):361-379.
  • Noureddin M, Lam J, Peterson M, Middleton M, Hamilton G, Le TA, Bettencourt R, Changchien C, Brenner DA, Sirlin C, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology. 2013;58(6):1930-1940.
  • Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A, Merriman R, Hameed B, Doo E, Kleiner DE, et al. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology. 2013;58(5):1644-1654.

Show moreShow less

English / Arabic

Make an Appointment




Available 24 Hours A Day


Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Mazen Noureddin, MD